Clinical and social factors associated with attention-deficit hyperactivity disorder medication use: population-based longitudinal study.

Br J Psychiatry

Cédric Galéra, MD, PhD, University of Bordeaux, Department of Child and Adolescent Psychiatry, Charles Perrens Hospital and INSERM, The Bordeaux School of Public Health (Institut de Santé Publique, d'Epidémiologie et de Développement), Centre INSERM U897, Epidemiology-Biostatistics, Bordeaux, France; Jean-Baptiste Pingault, PhD, Research Unit on Children's Psychosocial Maladjustment, University of Montreal and Sainte-Justine Hospital, Montreal, Canada and INSERM U669, Paris, France; Grégory Michel, PhD, University of Bordeaux, Psychology and Quality of Life, Bordeaux, France; Manuel-Pierre Bouvard, MD, University of Bordeaux, Department of Child and Adolescent Psychiatry, Charles Perrens Hospital, Bordeaux, France; Maria Melchior, ScD, INSERM U1018, Centre for Research in Epidemiology and Population Health, Epidemiology of Occupational and Social Determinants of Health, Villejuif, France; Bruno Falissard, MD, PhD, INSERM U669, Paris, France; Michel Boivin, PhD, International Laboratory for Child and Adolescent Mental Health, Department of Psychology, Laval University, Quebec City, Canada and Institute of Genetic, Neurobiological and Social Foundations of Child Development, Tomsk State University, Russian Federation; Richard E. Tremblay, PhD, Research Unit on Children's Psychosocial Maladjustment, University of Montreal and Sainte-Justine Hospital, Montreal, International Laboratory for Child and Adolescent Mental Health, University of Montreal, Montreal, Departments of Pediatrics, Psychiatry, and Psychology, University of Montreal, Montreal, Canada and School of Public Health, Physiotherapy, and Population Sciences, University College Dublin, Ireland and Institute of Genetic, Neurobiological and Social Foundations of Child Development, Tomsk State University, Russian Federation; Sylvana M. Côté, PhD, Research Unit on Children's Psychosocial Maladjustment, University of Montreal and Sainte-Justine Hospital, Montreal and International Laboratory for Child and

Published: October 2014

Background: The impact of longitudinal psychiatric comorbidity, parenting and social characteristics on attention-deficit hyperactivity disorder (ADHD) medication use is still poorly understood.

Aims: To assess the baseline and longitudinal influences of behavioural and environmental factors on ADHD medication use.

Method: Survival regressions with time-dependent covariates were used to model data from a population-based longitudinal birth cohort. The sample (n = 1920) was assessed from age 5 months to 10 years. Measures of children's psychiatric symptoms, parenting practices and social characteristics available at baseline and during follow-up were used to identify individual and family-level features associated with subsequent use of ADHD medication.

Results: Use of ADHD medication ranged from 0.2 to 8.6% between ages 3.5 to 10 years. Hyperactivity-inattention was the strongest predictor of medication use (hazard ratio (HR) = 2.75, 95% CI 2.35-3.22). Among all social variables examined, low maternal education increased the likelihood of medication use (HR = 2.09, 95% CI 1.38-3.18) whereas immigrant status lowered this likelihood (HR = 0.40, 95% CI 0.17-0.92).

Conclusions: Beyond ADHD symptoms, the likelihood of receiving ADHD medication is predicted by social variables and not by psychiatric comorbidity or by parenting. This emphasises the need to improve global interventions by offering the same therapeutic opportunities (including medication) as those received by the rest of the population to some subgroups (i.e. immigrants) and by diminishing possible unnecessary prescriptions.

Download full-text PDF

Source
http://dx.doi.org/10.1192/bjp.bp.113.141952DOI Listing

Publication Analysis

Top Keywords

adhd medication
16
attention-deficit hyperactivity
8
hyperactivity disorder
8
medication
8
population-based longitudinal
8
psychiatric comorbidity
8
comorbidity parenting
8
social characteristics
8
social variables
8
adhd
6

Similar Publications

Maternal Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes During Childhood and Early Adult Life.

J Clin Psychiatry

January 2025

Department of Psychiatry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India, Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India

Cannabis use during pregnancy is increasing; the study of adverse outcomes in cannabis-exposed pregnancies is therefore important. Previous articles in this series described increased risks of maternal adverse outcomes, fetal adverse outcomes, birth defects in newborns, and autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) in childhood. This article examines neuropsychiatric adverse outcomes in offspring gestationally exposed to cannabis.

View Article and Find Full Text PDF

Despite the exponential increase in the incidence rate of Autism spectrum disorder (ASD), effective therapies for the disorder are still limited. According to vast clinical observations, the pathogeneses of ASD and Attention-deficit hyperactivity disorder (ADHD) share a great deal of similarities. This serves as a prompt to investigate, in this study, whether patients with ADHD are at a higher risk for ASD, which is significant for disease prevention.

View Article and Find Full Text PDF

Background: Attention deficit/hyperactivity disorder (ADHD) is a disorder characterized by inattention, hyperactivity, and impulsivity. Primary pharmacologic interventions include stimulants and non-stimulants. Diagnosing ADHD is typically more difficult in women due to a range of different symptoms between the sexes.

View Article and Find Full Text PDF

Introduction: This study describes epidemiology of attention deficit hyperactivity disorder (ADHD) and use of ADHD medication across all age groups in Finland.

Methods: This retrospective study is based on nationwide registers in Finland. The study population included individuals with ADHD diagnosis and/or an ADHD medication record at least once during 2015-2020.

View Article and Find Full Text PDF

Background: Persisting post-concussion symptoms (PPCS) is a condition characterized by prolonged recovery from a mild traumatic brain injury (mTBI) and compromised quality of life. Previous literature, on the basis of small sample sizes, concludes that there are several risk factors for the development of PPCS.

Objective: We seek to identify protective and risk factors for developing slow recovery or persisting post-concussion symptoms (PPCS) by analyzing medical history, contact sport level, setting, and the Sport Concussion Assessment Tool (SCAT) and Brief Symptom Inventory (BSI-18) assessments at baseline and post-injury.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!